560 related articles for article (PubMed ID: 19960266)
21. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
Boland GW; Blake MA; Holalkere NS; Hahn PF
AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
[TBL] [Abstract][Full Text] [Related]
22. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
23. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
24. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography.
Thomas AJ; Habra MA; Bhosale PR; Qayyum AA; Ahmed K; Vicens R; Elsayes KM
Abdom Radiol (NY); 2018 Nov; 43(11):3101-3108. PubMed ID: 29671009
[TBL] [Abstract][Full Text] [Related]
25. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
28. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
29. High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology.
Lumachi F; Borsato S; Tregnaghi A; Marino F; Fassina A; Zucchetta P; Marzola MC; Cecchin D; Bui F; Iacobone M; Favia G
Tumori; 2007; 93(3):269-74. PubMed ID: 17679462
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound.
Friedrich-Rust M; Glasemann T; Polta A; Eichler K; Holzer K; Kriener S; Herrmann E; Nierhoff J; Bon D; Bechstein WO; Vogl T; Zeuzem S; Bojunga J
Ultraschall Med; 2011 Oct; 32(5):460-71. PubMed ID: 21667434
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass.
Al-Hawary MM; Francis IR; Korobkin M
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):277-92. PubMed ID: 15763701
[TBL] [Abstract][Full Text] [Related]
33. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
34. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
35. Radiological localizing techniques in adrenal tumors.
Welsh SJ; Khan S
Minerva Endocrinol; 2009 Jun; 34(2):161-9. PubMed ID: 19471240
[TBL] [Abstract][Full Text] [Related]
36. Dual-energy CT for characterization of adrenal nodules: initial experience.
Gupta RT; Ho LM; Marin D; Boll DT; Barnhart HX; Nelson RC
AJR Am J Roentgenol; 2010 Jun; 194(6):1479-83. PubMed ID: 20489086
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
38. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
40. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?
Song JH; Grand DJ; Beland MD; Chang KJ; Machan JT; Mayo-Smith WW
AJR Am J Roentgenol; 2013 Dec; 201(6):1248-53. PubMed ID: 24261363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
